Skip to main content

Advertisement

Log in

Antibiotic Prophylaxis in Pediatric Urology: An Update

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

This article discusses the use of antibiotic prophylaxis in the treatment of three common conditions encountered by the pediatric urologist: 1) children with urinary infection and structurally and neurologically normal urinary tracts; 2) children with vesicoureteral reflux (VUR); and 3) children with prenatally diagnosed ureteropelvic and ureterovesical obstruction. The literature remains unclear and contradictory. Additional significant risk factors for recurrent infection are age, circumcision status in boys, and toileting function. The evidence for the use of prophylaxis is best in those with VUR, although not everyone with VUR must be on medication. In the absence of definitive evidence, the clinician must individualize the treatment of each patient and family.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Wan J, Kaplinsky R, Greenfield, SP: Toilet habits of children evaluated for urinary tract infection. J Urol 1995, 154:797–799.

    Article  PubMed  CAS  Google Scholar 

  2. Farhat W, Bagli DJ, Capolicchio G, et al.: The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol 2000, 164:1011–1015.

    Article  PubMed  CAS  Google Scholar 

  3. Conway PH, Cnaan A, Zaoutis T, et al: Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007, 298:179–186.

    Article  PubMed  CAS  Google Scholar 

  4. Craig JC, Simpson JM, Williams GJ, et al.: Antibiotic prophylaxis and recurrent urinary tract infection in children. NEJM 2009, 361:1748–1759.

    Article  PubMed  CAS  Google Scholar 

  5. • Williams G, Craig JC: Prevention of recurrent urinary tract infection in children. Curr Op Inf Dis 2009, 22:72–76. This was a large prospective study of children with and without reflux, showing a slight advantage to prophylaxis.

    Article  Google Scholar 

  6. Mori R, Fitzgerald A, Williams C, et al.: Antibiotic prophylaxis for children at risk of developing urinary tract infection: a systemic review. Acta Paed 2009, 98:1781–1786.

    Article  Google Scholar 

  7. Montini G, Rigon L, Zuchetta P, et al.: Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled noninferiority trial. Pediatrics 2007, 122:1064–1071.

    Article  Google Scholar 

  8. Williams G, Wei L, Lee A, et al.: Long term antibiotics for preventing recurrent urinary tract infection in children (review). Cochrane Collaboration in the Cochrane Library 2009, John Wiley & Sons, Ltd pp 1–28.

  9. Cascio S, Colhoun E, Puri P: Bacterial colonization of the prepuce in boys with vesicoureteral reflux who receive antibiotic prophylaxis. J Peds 2000, 139:160–162.

    Article  Google Scholar 

  10. Fisch N, Ashkenazi S, Davidowitz M: Prophylactic antibiotics and evaluation scheme following febrile urinary tract infection in children: a nationwide Israeli survey. IMAJ 2009, 11:677–682.

    PubMed  Google Scholar 

  11. Chevalier I, Benoit G, Gauthier M, et al.: Antibiotic prophylaxis for childhood urinary tract infection: a national survey. J Ped Child Health 2008, 44:572–578.

    Article  Google Scholar 

  12. Cheng CH, Ming-Horng T, Yhu-Chering H, et al.: Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Peds 2008, 122:1212–1217.

    Article  Google Scholar 

  13. Lee SJ, Shim YH, Cho SJ, et al.: Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol 2007, 22:1315–1320.

    Article  PubMed  Google Scholar 

  14. Greenfield SP, Ng M, Wan J: Experience with vesicoureteral reflux in children: clinical characteristics. J Urol 1997, 158:574–577.

    Article  PubMed  CAS  Google Scholar 

  15. Cooper CS, Chung BI, Kirsch AJ, et al.: The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux. J Urol 2000, 163:269–273.

    Article  PubMed  CAS  Google Scholar 

  16. Garin EH, Olavarria F, Garcia NV, et al.: Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Peds 2006, 117:626–632.

    Article  Google Scholar 

  17. Roussey-Kesler G, Gadjos V, Idres N, et al.: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol 2008, 179:674–679.

    Article  PubMed  CAS  Google Scholar 

  18. Brandstrom P, Esbjorner E, Herthelius M, et al.: The Swedish reflux trial in children: I. Study design and study population characteristics. J Urol 2010, 184:274–279.

    Article  PubMed  Google Scholar 

  19. •• Brandstrom P, Esbjorner E, Herthelius M, et al.: The Swedish reflux trial in children: III. Urinary tract infection pattern. J Urol 2010, 184:286–291. The authors studied a well-defined group of children with grade 3 or 4 reflux who had a significant decrease in recurrent infections on prophylaxis.

    Article  PubMed  Google Scholar 

  20. •• Brandstrom P, Neveus T, Sixt R, et al.: The Swedish reflux trial in children: IV. Renal Damage. J Urol 2010, 184:292–297. The authors studied a well-defined group of children with grade 3 or 4 reflux who had significant prevention of new renal scarring while on prophylaxis.

    Article  PubMed  Google Scholar 

  21. Sillen U, Brandstrom P, Jodal U, et al.: The Swedish reflux trial in children: V. Bladder dysfunction. J Urol 2010, 184:298–304.

    Article  PubMed  Google Scholar 

  22. Al-Sayyad A, Pike J, Leonard MP: Can prophylactic antibiotics safely be discontinued in children with vesicoureteral reflux? J Urol 2005, 174:1587–1589.

    Article  PubMed  Google Scholar 

  23. Georgaki-Angelaki H, Kostaridou S, Daikos GL, et al.: Long-term follow-up of children with vesicoureteral reflux with and without antibiotic prophylaxis. Scand J Inf Dis 2005, 37:842–845.

    Article  CAS  Google Scholar 

  24. Kitchens DM, Herndon A, Joseph DB: Outcome after discontinuing prophylactic antibiotics in children with persistent vesicoureteral reflux. J Urol 2010, 184:1594–1597.

    Article  PubMed  Google Scholar 

  25. •• Peters CA, Skoog SJ, Arant BS, et al.: Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 2010, 184:1134–1144. This is the most comprehensive meta-analysis of the literature, with well-reasoned conclusions regarding therapy.

    Article  PubMed  Google Scholar 

  26. •• Keren R, Carpenter MA, Hoberman A, et al.: Rationale and design issues of the randomized intervention for children with vesicoureteral reflux (RIVUR) study. Peds 2008, 5(Suppl):5240–5250. This article provides a comprehensive discussion of the RIVUR trial and its aims.

    Google Scholar 

  27. • Greenfield SP, Chesney RW, Carpenter M, et al.: Vesicoureteral reflux: the RIVUR study and the way forward. J Urol 2008, 179:405–407. This article provides a succinct analysis of the shortcomings of the current literature and a brief description of the RIVUR trial.

    Article  PubMed  Google Scholar 

  28. Copp HL, Nelson CP, Shortliffe LD, et al.: Compliance with antibiotic prophylaxis in children with vesicoureteral reflux: results from a national pharmacy claims data base. J Urol 2010, 183:1994–2000.

    Article  PubMed  Google Scholar 

  29. Wan J, Greenfield SP, Talley M, et al.: An analysis of social and economic factors associated with followup of patients with vesicoureteral reflux. J Urol 1996, 156:668–672.

    Article  PubMed  CAS  Google Scholar 

  30. Ogan K, Pohl H, Carlson D, et al.: Parental preferences in the management of vesicoureteral reflux. J Urol 2001, 240–243.

  31. Woodward M, Frank D: Postnatal management of antenatal hydronephrosis. BJU Int 2002, 89:149–156.

    Article  PubMed  CAS  Google Scholar 

  32. Lee JH, Choi HS, Kim JK, et al.: Nonrefluxing neonatal hydronephrosis and the risk of urinary tract infection. J Urol 2008, 179:1524–1528.

    Article  PubMed  Google Scholar 

  33. • Roth CC, Hubanks JM, Bright BC, et al.: Occurence of urinary tract infection in children with significant upper urinary tract obstruction. Urology 2009, 73:74–78. The authors studied a well-defined group of infants with prenatally diagnosed UPJO and UVJO who were followed off prophylaxis.

    Article  PubMed  Google Scholar 

  34. Greenfield SP, Deshmukh S, Williot P: Prenatally detected primary ureterovesical junction obstruction: are prophylactic antibiotics necessary? Presented at the Urology Section, American Academy of Pediatrics, Washington, DC October 2009.

    Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Saul P. Greenfield.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greenfield, S.P. Antibiotic Prophylaxis in Pediatric Urology: An Update. Curr Urol Rep 12, 126–131 (2011). https://doi.org/10.1007/s11934-010-0164-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-010-0164-y

Keywords

Navigation